Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bionano Genomics, Inc. develops and markets optical genome mapping (OGM) systems, software, and nucleic acid purification solutions for comprehensive structural variation (SV) analysis in genomics. Its core products include the Saphyr® and Stratys™ OGM systems, VIA™ software for integrated genomic data interpretation, and the Ionic® Purification system. Serving researchers, clinicians, and biopharmaceutical companies, Bionano’s platform offers a scalable, cost-effective alternative to traditional cytogenetics and sequencing for genetic disease, cancer, and cell therapy applications.
This description was generated via AI from an annual report. Updated about 1 year ago.